title: Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion.
abstract: Patients preparing to undergo gonadotoxic medical therapy or radiation therapy or gonadectomy should be provided with prompt counseling regarding available options for fertility preservation. Fertility preservation can best be provided by comprehensive programs designed and equipped to confront the unique challenges facing these patients.
authors.affiliation: American Society for Reproductive Medicine, Birmingham, Alabama.
mesh_terms: D000367:Age Factors; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002369:Castration / Q000009:adverse effects*; D005260:Female; D005298:Fertility / Q000187:drug effects / Q000528:radiation effects; D059247:Fertility Preservation / Q000009:adverse effects / Q000379:methods / Q000592:standards*; D006066:Gonads / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology / Q000528:radiation effects / Q000601:surgery; D006801:Humans; D007246:Infertility / Q000209:etiology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D010348:Patient Care Team / Q000592:standards; D018579:Patient Selection; D011832:Radiation Injuries / Q000209:etiology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D011878:Radiotherapy / Q000009:adverse effects; D018570:Risk Assessment; D012307:Risk Factors; D012737:Sex Factors
chemical_list: D000970:Antineoplastic Agents